Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2010
10/14/2010US20100261773 3.3.0 BICYCLIC GlyT1 INHIBITORS AND METHODS OF MAKING AND USING SAME
10/14/2010US20100261675 Fungicidal composition containing acid amide derivative
10/14/2010US20100261608 Geminal alkoxy/alkylspirocyclic substituted tetramate derivatives
10/14/2010US20100260709 Organic compounds and their uses
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2757934A1 Crystal forms of saxagliptin
10/13/2010EP2238988A1 Conjugated prodrugs of cc-1065 analogs
10/13/2010EP2238108A1 Salt forms of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative, process for their manufacture and pharmaceutical compositions containing same
10/13/2010EP2238107A1 Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative
10/13/2010EP1656347B1 Substituted indole derivatives for pharmaceutical composition for treating respiratory diseases
10/13/2010EP1458734B1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer
10/13/2010EP1252803B1 Complexes of form l2mx as phosphorescent dopants for organic leds
10/13/2010CN1916760B Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
10/13/2010CN101861291A Benzochrysene derivative and organic electroluminescent device using the same
10/13/2010CN101857564A Method for removing dioxane from Ftibamzone raw material
10/13/2010CN101857548A Two-aromatic amino terminated dianthracene compound, preparation method and application thereof
10/13/2010CN101492413B Fine purification method for carprofen
10/12/2010US7812036 Androgens
10/12/2010US7812017 such as 1-(Phenylsulfonyl)-4-(piperazin-1-ylmethyl)-1H- indole, hydrochloride, used as dietetics, selective serotonin receptor antagonists or in cosmetics
10/12/2010CA2480038C Substituted 4-aminocyclohexanols
10/12/2010CA2478283C Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
10/12/2010CA2441110C Pharmaceutical compositions for treating arteriosclerosis
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/07/2010WO2010114267A2 Organic electronic device, compounds for same, and terminal
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010113183A2 Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010US20100256393 Process for the preparation of 6,6- dimethyl-3-azabicyclo-[3.1.0]-hexane compounds and enantiomeric salts thereof
10/07/2010US20100256388 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
10/07/2010US20100256192 3.1.0 bicyclic glyt1 inhibitors and methods of making and using same
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256106 Tryptamine sulfonamides as 5-ht6 antagonists
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/06/2010EP2236495A1 New salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them
10/06/2010EP2234993A1 Bis- (sulf onylamino) derivatives for use in therapy
10/06/2010EP2234970A1 Anthracene derivative, and light-emitting material, light-emitting element, light-emitting device, and electronic device using the same
10/06/2010EP2234969A2 Carbazole-based hole transport and /or electron blocking materials and /or host polymer materials
10/06/2010EP2234968A1 (aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/06/2010EP2234485A1 Stable laquinimod preparations
10/06/2010EP1751093B1 Substituted cyclohexylacetic acid derivatives
10/06/2010CN101855207A Improved ramipril synthesis
10/06/2010CN101855206A N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/06/2010CN101851243A Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/06/2010CN101851230A Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
10/06/2010CN101851191A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
10/06/2010CN101851190A Biscarbazol-9-yl-substituted triarylamine-containing polymers and electronic devices
10/06/2010CN101851189A Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/05/2010US7807845 Enzyme inhibitor for treating HIV infections; viricides; patient is suffering from a multi-drug resistant HIV infection; AIDS therapy; {1-Benzyl-3-[(3-dimethylaminomethylene-2-oxo-2,3-dihydro-1H-indole-5-sulfonyl)-isobutyl-amino]-2-hydroxy-propyl}-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807707 inflammatory skin conditions such as scalp skin itching and flaking associated with dandruff; shampoo; naphthalen-1-ylamino)-acetic acid (2-oxo-1-phenethyl-1,2-dihydro-indol-3-ylidene)-hydrazide
10/05/2010US7807706 5-bromo-2-[4-(2-fluorophenoxy)benzyl]-7-methyl-2,3-dihydro-isoindol-1-one; central nervous system, neural plasticity, neural development and neurodegeneration
10/05/2010US7807705 [1-(3'-nitro-4'-chlorobenzenesulfonyl)-1H-indol-3-yl]-methanol, used for inducing apoptosis in unwanted rapidly proliferating cells, treating, inhibiting or delaying the onset of cancer
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010CA2441331C Bicyclic guanidine derivatives and therapeutic uses thereof
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
09/2010
09/30/2010WO2010110545A2 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
09/30/2010WO2010110353A1 Novel amide derivative and skin whitening agent
09/30/2010WO2010109230A1 Novel prodrugs
09/30/2010WO2010109008A1 Prodrugs of substituted 3-(4-hydroxyphenyl)-indolin-2-ones
09/30/2010WO2010108856A1 Leukotriene b4 inhibitors
09/30/2010WO2010108384A1 Phosphor-nitrogen ligand derived from tetrahydroquinoline and indoline, preparation method and use thereof
09/30/2010WO2010054330A3 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
09/30/2010WO2010003022A8 Isoindolone derivatives as mek kinase inhibitors and methods of use
09/30/2010US20100249433 Process for the purification of ropinirole hydrochloride
09/30/2010US20100249349 Novel Polymers
09/30/2010US20100249276 Curatives for epoxy compositions
09/30/2010US20100249204 Calcium salts of indole derived statins
09/30/2010US20100249201 3-3-Di-Substituted-Oxindoles As Inhibitors of Translation Initiation
09/30/2010US20100249197 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100248261 Method to determine protein interaction sites
09/30/2010US20100247707 Dipeptides as feed additives
09/30/2010US20100247659 Phenylphthalimide analogs for treating diabetic macular edema
09/30/2010US20100245217 Carbazole derivative, light-emitting element material, light-emitting element, light-emitting device, electronic device, and lighting device
09/30/2010US20100244008 compound and organic light emitting device using the same
09/30/2010CA2756887A1 Indole derivatives
09/30/2010CA2754085A1 Novel hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same
09/30/2010CA2747327A1 Leukotriene b4 inhibitors
09/29/2010EP2233512A1 Polythioetherimides and method for producing thereof
09/29/2010EP2233486A1 Azaindoles
09/29/2010EP2233466A1 4-Alkoxy-1-amino-1-cyclohexanecarboxylic acid derivatives and their use as intermediates
09/29/2010EP2231814A1 An electrochromic composition, a method of forming the electrochromic composition and an electrochromic apparatus
09/29/2010EP2231598A1 Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
09/29/2010EP2231570A1 Rhodium-phosphorus complexes and their use in ring opening reactions
09/29/2010EP1675824B1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists
09/29/2010EP1534695B1 Tyrosine kinase inhibitors
09/29/2010EP1399411B1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
09/29/2010CN1860364B Fluorescently tagged ligands
09/29/2010CN1821217B Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
09/29/2010CN1794987B Nitrooxyderivatives of fluvastatin, pravastatin, cerivastatin, atorvastatin and rosuvastatin as cholesterol-reducing agents with improved anti-inflammatory, antithrombotic and antiplatelet activity
09/29/2010CN101848908A Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
09/29/2010CN101848892A Hydrobenzamide derivatives as inhibitors of HSP90
09/29/2010CN101848891A Preparation of synthetic nucleosides via [pi]-allyl transition metal complex formation
09/29/2010CN101845012A Method for synthesizing N-hydroxy phthalimide with solid-phase process
09/29/2010CN101302183B Preparation of 5-substituted-1-(3-hydroxypropyl)-7-carbamyl indoline
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 458